AEPGX
Price
$62.17
Change
-$0.34 (-0.54%)
Updated
Aug 26 closing price
Net Assets
134.64B
RIVLX
Price
$19.75
Change
-$0.11 (-0.55%)
Updated
Aug 26 closing price
Net Assets
2.55B
Interact to see
Advertisement

AEPGX vs RIVLX

Header iconAEPGX vs RIVLX Comparison
Open Charts AEPGX vs RIVLXBanner chart's image
American Funds EUPAC A
Price$62.17
Change-$0.34 (-0.54%)
VolumeN/A
Net Assets134.64B
American Funds International Vntg R-5
Price$19.75
Change-$0.11 (-0.55%)
VolumeN/A
Net Assets2.55B
AEPGX vs RIVLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPGX vs. RIVLX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Buy and RIVLX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 135B vs. RIVLX (2.55B). RIVLX pays higher dividends than AEPGX: RIVLX (1.37) vs AEPGX (0.70). AEPGX was incepted earlier than RIVLX: AEPGX (41 years) vs RIVLX (6 years). AEPGX (0.83) is less costly to investors than RIVLX (0.60). AEPGX is a more actively managed with annual turnover of: 35.00 vs. RIVLX (20.00). AEPGX (250) and RIVLX (250) have matching initial minimum investment requirements. RIVLX annual gain was more profitable for investors over the last year : 12.24 vs. AEPGX (5.70). RIVLX return over 5 years is better than : 38.25 vs. AEPGX (9.93).
AEPGXRIVLXAEPGX / RIVLX
Total Expense Ratio0.830.60138%
Annual Report Gross Expense Ratio0.830.60138%
Fund Existence41 years6 years-
Gain YTD15.73021.38974%
Front Load6%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets135B2.55B5,300%
Annual Yield % from dividends0.701.3751%
Returns for 1 year5.7012.2447%
Returns for 3 years30.3648.9862%
Returns for 5 years9.9338.2526%
Returns for 10 years37.55N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INKT15.150.58
+3.98%
MiNK Therapeutics Inc
RM41.480.50
+1.22%
REGIONAL MANAGEMENT Corp
HP18.950.18
+0.96%
Helmerich & Payne
ENSG170.680.72
+0.42%
Ensign Group (The)
XOMAP25.77-0.27
-1.04%
XOMA Corp